Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes
Dr. Diana Isaacs on improving time in range, making the most of your data, and the barriers facing people with diabetes and their healthcare teams
Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on...
Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices
The Time in Range Coalition aims to help millions of people by promoting time in range in diabetes care
Michael writes about how he used two main strategies – intermittent fasting and walking after meals ­– to put his type 2 diabetes into remission
More time in range and lower stress! In this Trial Watch, Kerri Sparling shares her experience with Tandem's Control-IQ
The diaTribe team was on the ground in Madrid, Spain to cover the latest news in diabetes technology from ATTD. Here are our top highlights from the conference!
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
A low carb diet can be difficult to follow, especially for children. Katie Bacon explains several ways in which low carb principles can be adapted to real life
As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...
FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...
A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease
Diabetes advocates, Renza and Grumpy, share the importance of #LanguageMatters and the consequences of “grading” diabetes management
What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019
What is it like having a sibling with diabetes, and what can someone do to support their sibling with diabetes? 20-year-old Alexandra Varon shares insight on having a...
The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable...
The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
This currently recruiting study will support FDA submission of Tandem’s Control-IQ hybrid closed loop for children six years of age or older
Control-IQ Hybrid Closed Loop on track to launch in the US by the end of 2019 for those ages 14 and older; first system with automatic correction boluses and no...

Pages